期刊文献+

通络方剂对糖尿病大鼠PAI-1及血流变的作用 被引量:1

Effects of Tongluo recipe on PAI-1 and hemorheology in rats with diabetic mellitus
下载PDF
导出
摘要 目的观察通络方剂(Tongluo Recipe,TLR)对糖尿病(Diabetes Mellitus,DM)大鼠PAI-1及血流变的作用,并探讨其可能机制。方法雄性SD大鼠腹腔注射链脲佐菌素(Streptozocin,STZ,60 mg/kg),1型糖尿病成模后,随机分为糖尿病组(DM),高剂量通络方剂组(HT,1 g.kg-1.d-1),低剂量通络方剂组(LT,0.5 g.kg-1.d-1),并设鼠龄、体重相匹配的正常对照组(NC),每组8只。12 w后ELISA法测定血浆纤溶酶原激活物抑制剂-1(Plasminogen activator inhibitor-1,PAI-1)含量,同时测定红细胞变形指数(EDI)和红细胞聚集指数(ECI)等血流变指标。结果NC组PAI-1含量(1.99±0.51)明显低于其他各组(P<0.01),DM组的PAI-1含量(11.36±0.60)高于HT组(4.25±0.73)及LT组(7.74±0.82)(P<0.05),HT组PAI-1含量低于LT组(P<0.05)。NC组、DM组EDI低于HT组及LT组(P<0.05),ECI高于HT及LT组。结论TLR可能通过改善血管内皮功能,抑制糖尿病大鼠PAI-1的生成,减少微血管血栓形成,对糖尿病大鼠血管病变具有保护作用。 Objective To investigate the effect of Tongluo recipe (TLR) on plasminogen activator inhibitor (PAI) -1 and hemorheology in rats with diabetic mellitus. Methods The male type 1 diabetic model SD rats given with streptozotocin 60 mg/kg were divided into normal control group (NC), diabetes mel]itus (DM) group, high dose TLR (HT) group and low dose TLR (LT) group, 8 rats in each group. Plasma PAI-1 in the four groups was detected by ELISA, erythrocyte deformation index (EDI) and erythrocyte concentration index (ECI) were determined 12 weeks later. Results The concentrations of PAI-1 in NC group were significantly lower than that in other groups ( P 〈 0.01 ) ; that in DM group was higher than that in TLR group ( P 〈 0. 05 ) ; that in HT group was lower than that in LT group ( P 〈 0. 05 ) . The EDI in DM and NC group was lower than that in TLR group(P 〈0.05) ; the ECI in DM and NC group was higher than that in TLR group. Conclusions DM rats have the increased plasma PAI-1 contents and ECI, and the decreased EDI. TLR may adjust the function of endothelium and inhibit the produce of PAI-1 to improve hemodynamics of DM, so it can decrease the incidence of microthrombus. TLR can protect the vascular structure and function in rats with DM.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2007年第18期1756-1758,共3页 Chinese Journal of Gerontology
基金 国家重点基础研究发展计划(973计划)(2005CB523304)
关键词 糖尿病 通络方剂 PAI-1 Diabetic Mellitus Tongluo recipe Plasminogen activator inhibitor (PAI-1)
  • 相关文献

参考文献15

二级参考文献33

  • 1赵毅,张显林.通心络胶囊对糖尿病肾病患者血浆内皮素的影响[J].中国中西医结合杂志,2005,25(2):131-133. 被引量:16
  • 2涂晓文,陈英剑,张爱平,胡成进,王艳侠.褪黑素对糖尿病大鼠肾脏抗氧化物酶的影响[J].中华糖尿病杂志(1006-6187),2005,13(4):302-303. 被引量:4
  • 3Cho YW,Yang DH,Oh DY,et al.Plasma t—PA and PAI antigen concentrations in non—insulin dependent diabetic patients:implication for diabetes retinopathy.Diabetes Res Clin Praet,1994,22:123~128.
  • 4Nahloo A,Mohamed—Ali V.Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.Diabetes.1995,44(1):37.
  • 5Ceriello A.New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.Diabetes Care 2003;26(5):1589-96.
  • 6Brownlee M.Biochemistry and molecular cell biology of diabetic complications.Nature 2001;414(6865):813-20.
  • 7Ha H,Yu MR,Choi YJ,et al.Role of high glucose-induced nuclear factorkappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells.J A m Soc Nephrol 2002;13(4):894-902.
  • 8Thannickal VJ,Fanburg BL.Reactive oxygen species in cell signaling.A m J Physiol Lung Cell Mol Physiol 2000;279(6):L1005-28.
  • 9Ha H,Yang Y,Lee HB,et al.Mechamisms of reactive oxygen species generation in LLC-PK1 cells cultured under high glucose.J Am Soc Nephrol 2002; 13:531.
  • 10Green K,Brand MD,Murphy MP.Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes.Diabetes 2004;53 Suppl 1:S110-8.

共引文献18

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部